Blog - Page 57 of 5617 - QualityStocks

MondayFeb 23, 2026 9:45 am

MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) Natural Hydrogen Vision Gains Momentum with Major $5M Investment

Disseminated on behalf of MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) and may include paid advertising. The investment marks the first major investment by a Vietnam-based company into Saskatchewan’s emerging Natural Hydrogen sector. MAX Power Mining is among the first publicly traded companies in North America focused on commercial-scale Natural Hydrogen development. This funding round follows a series of other strategic moves by MAX Power aimed at positioning the company for success. MAX Power Mining (CSE: MAXX) (OTC: MAXXF) has announced a significant financial milestone this week, revealing the successful closing of a $5 million non-brokered private placement with…

MondayFeb 23, 2026 9:40 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured In NetworkNewsAudio On Biotech M&A Trends

Oncotelic Therapeutics (OTCQB: OTLC) is featured in a NetworkNewsAudio Audio Press Release titled “Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A,” highlighting growing investor interest in clinical-stage platforms supported by existing human data. The editorial notes that programs demonstrating clinical activity offer clearer valuation benchmarks and reduced uncertainty compared with preclinical assets, positioning companies with diversified clinical pipelines, including oncology and CNS-focused targets such as TGF-β signaling and delivery-based approaches, to align with industry demand for validated mechanisms and strategic portfolio depth. To view the full press release, visit https://ibn.fm/cZmVn About Oncotelic Therapeutics Inc. Oncotelic Therapeutics…

MondayFeb 23, 2026 9:30 am

QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Projects Over 500% Q1 Revenue Growth As Government Deployment Accelerates

Safe Pro Group (NASDAQ: SPAI) announced it expects first quarter 2026 revenue to increase more than 500% year-over-year, driven by initial deliveries under a recently awarded $1,000,000 U.S. Government subcontract supporting deployment of its AI-Powered Edge Processing platform. Based on preliminary, unaudited results, the company said the acceleration reflects its transition from development-stage operations into revenue-generating government programs, supported by low-rate initial production, a strengthened balance sheet following a $14 million PIPE financing in Q4 2025 led by Ondas Holdings Inc. (NASDAQ: ONDS) and Unusual Machines Inc. (NYSE American: UMAC), and commercialization of its patented Safe Pro Object Threat Detection…

MondayFeb 23, 2026 9:10 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Updates Distribution Date For Warrant And Token Dividends

Datavault AI (NASDAQ: DVLT) announced that its board of directors has changed the distribution date for its previously declared dividend of warrants to purchase common stock and its dividend of Dream Bowl Meme Coin II tokens to Feb. 27, 2026, from Feb. 23, 2026, and Feb. 21, 2026, respectively, while the record date remains Jan. 7, 2026. The board retains discretion to further change or revoke the distributions prior to the distribution date, and the company intends to file a prospectus supplement to its Form S-3 shelf registration statement with the SEC registering the warrant distribution and the shares issuable…

MondayFeb 23, 2026 9:00 am

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands into Proton Therapy Through Liora Technologies, Advancing the LiGHT System for Next-Generation Cancer Care

LIXTE has acquired Liora Technologies Europe Ltd., securing its proprietary LiGHT system for advanced proton therapy treatment Liora works at the forefront of electronically controlled proton beam innovation, with its platform installed at the UK’s STFC Daresbury Laboratory These updates highlight LIXTE’s overarching mission to blend breakthrough drug development with transformative radiotherapy innovations in the global cancer fight Cancer is still one of the most widespread life-threatening diseases globally, with nearly all families affected either directly or as caregivers. Innovations in the medical ecosystem continue to gain momentum with the emergence of new immunotherapies, targeted drugs, and advanced radiation treatments.…

MondayFeb 23, 2026 9:00 am

QualityStocksNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Announces Key Management Appointments At Ambler Metals Joint Venture

This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) announced senior management appointments at its 50/50 joint venture with South32 Limited, Ambler Metals LLC, which is advancing the Upper Kobuk Mineral Projects in Alaska’s Ambler Mining District. Michael Galicki has been named Vice President, Exploration; Cole Schaeffer Vice President, Human Resources, Community and Partnerships; Jenna Tan Vice President, Finance; and Ron Rimelman Senior Director, Permitting. The appointments strengthen Ambler Metals’ technical, financial and permitting leadership as it advances exploration drilling, community engagement, feasibility planning and expedited…

FridayFeb 20, 2026 3:03 pm

QualityStocksNewsBreaks – Mangoceuticals, Inc. (NASDAQ: MGRX) Reports 336% Sales Growth for $99 Monthly TRT Program

Mangoceuticals (NASDAQ: MGRX) operating under the MangoRx and PeachesRx brands, announced initial success for its newly launched all-inclusive injectable testosterone replacement therapy program priced at $99 per month, which includes doctor visits, consultations, lab work and prescribed medication. Since launching in mid-December, month-over-month sales of the injectable TRT program have increased 336% while customer acquisition costs declined 54%, reflecting what the company described as growing demand for convenient hormone health solutions delivered through its telehealth platform. MangoRx expects TRT to serve as a primary growth driver, alongside oral formulations including PRIME by MangoRx powered by Kyzatrex, as it seeks to expand its presence in the global TRT market, estimated at approximately $2.1 billion to $2.2 billion in 2025.…

FridayFeb 20, 2026 11:27 am

QualityStocksNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Secures Additional Israeli Defense Order for DefendAir Counter-UAS System

ParaZero Technologies (NASDAQ: PRZO), an aerospace defense company focused on autonomous solutions for manned and unmanned aerial systems, announced it has received an additional order from a second branch of an Israeli defense entity for its DefendAir(TM) multi-layered counter-UAS solution. The order follows an earlier successful deployment and includes specialized high-precision net launchers for urban and field use, interception pods compatible with handheld, stationary and drone-mounted configurations, and a comprehensive training package featuring simulation-based and live-fire modules. The company said recent demonstrations achieved 100% interception rates against high-speed threats, including FPV drones and heavy-lift platforms, highlighting DefendAir’s non-explosive, patent-protected net-based interception technology as a cost-effective alternative to traditional counter-drone systems. To…

FridayFeb 20, 2026 11:23 am

QualityStocksNewsBreaks – Neo-Concept International Group Holdings Limited (NASDAQ: NCI) Closes $8.1 Million Public Offering

Neo-Concept International Group Holdings (NASDAQ: NCI), a one-stop apparel solution services provider, announced the closing on Feb. 11, 2026 of its public offering of 14,850,000 Class A ordinary shares at a public offering price of $0.5454 per share, generating gross proceeds of approximately $8.1 million before fees and expenses. The company said it intends to use the net proceeds to expand its business and for general working capital. D. Boral Capital LLC acted as lead placement agent and uSmart Securities Limited served as joint placement agent. The offering was conducted pursuant to an effective Form F-1 registration statement declared effective by the SEC on Feb. 9, 2025 and was made only by means of a prospectus filed…

FridayFeb 20, 2026 11:15 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Bolsters Its Leadership with Galen Carson’s Appointment; On Track for First Gold and Silver Production in 2026

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising. ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, just announced the appointment of Galen Carson to its Advisory Board Mr. Carson will support ESGold across strategic planning, long-term value positioning, and capital markets engagement It follows the recent addition of 144 mining claims to its Montauban project, which brought the total claims to 417 The acquisition of these additional claims marked a critical inflection point for ESGold, with Mr. Carson’s appointment serving as a testament to…

Site Search

Company Search